Diosgenin ameliorates silica‐induced tuberculosis in rats
Animal Models and Experimental Medicine · 2025
DOI: 10.1002/ame2.70055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Williams Asamoah Adu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Applied Science and Technology, Sunyani Technical University, Sunyani, Ghana. Hauptthemen laut MEDLINE: Diosgenin, Silicon Dioxide, Silicosis, Tuberculosis. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Silicosis is an occupational lung disease that is caused by chronic exposure to silica dust. Silica‐exposed workers are at higher risk of developing TB, resulting in lung fibrosis and significant respiratory dysfunction. Diosgenin is a steroidal saponin that has been shown to exert a therapeutic effect on lung injury. Therefore, we investigated the potential efficacy of diosgenin in treating silicotuberculosis by evaluating its effectiveness against Mycobacterium smegmatis , as well as its antifibrotic and antioxidant effects in silica‐induced TB in rats.
Methods
Silicosis was induced by intratracheal instillation of 50 mg/kg crystalline silica in Sprague–Dawley rats. Rats were grouped into 7 (10 per group). Different doses of diosgenin (1, 10, and 20 mg/kg) and saline were administered for 30 days. Afterwards, five rats from each group were sacrificed, and the five remaining rats in each group, except the control, received Mycobacterium smegmatis . Treatment continued until the 50th day, and the animals were sacrificed at the end of the experiment. The result was analyzed using a one‐way analysis of variance (ANOVA) with GraphPad Prism.
Results
At a half‐maximal inhibition concentration of 0.006043 μg/mL, diosgenin inhibited the growth of Mycobacterium smegmatis . Oxidative stress markers such as malondialdehyde were significantly reduced. The health‐enhancing effects of catalase and superoxide dismutase were elevated. Additionally, histological findings demonstrated a significant improvement in respiratory function following diosgenin treatment.
Conclusion
Diosgenin treatment inhibited the growth of Mycobacterium smegmatis, leading to a reduction in the susceptibility of rats to infection and improved pulmonary function through its antioxidant effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Faculty of Applied Science and Technology, Sunyani Technical University, Sunyani, Ghana.
- Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, PMB, Kumasi, Ghana.
- Department of Medical Laboratory Science, University of Energy and Natural Resources, Sunyani, Ghana.
- Department of Pathology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
ORCID-Profile: Williams Asamoah Adu
Zitieren
APA
Adu, W. A., Ativui, S., Ofori, M., Owusu, G., Danquah, C. A., & Poku Sampene Ossei, P. (2025). Diosgenin ameliorates silica‐induced tuberculosis in rats. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.70055
Vancouver
Adu WA, Ativui S, Ofori M, Owusu G, Danquah CA, Poku Sampene Ossei P. Diosgenin ameliorates silica‐induced tuberculosis in rats. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.70055
BibTeX
@article{Adu2025,
author = {Adu, Williams Asamoah and Ativui, Selase and Ofori, Michael and Owusu, George and Danquah, Cynthia Amaning and Poku Sampene Ossei, Paul},
title = {Diosgenin ameliorates silica‐induced tuberculosis in rats},
journal = {Animal Models and Experimental Medicine},
year = {2025},
doi = {10.1002/ame2.70055}
}
EUVIMED